findmyKOL
Clinical trialNCT00234052CompletedPhase 2Interventional

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

SponsorNorthwestern UniversityEnrollment51Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Chicago, Illinois, United States

  • Rush Cancer Institute at Rush University Medical Center

    Chicago, Illinois, United States

  • Evanston Northwestern Healthcare - Evanston Hospital

    Evanston, Illinois, United States

  • Ingalls Cancer Care Center at Ingalls Memorial Hospital

    Harvey, Illinois, United States

  • Advocate Lutheran General Cancer Care Center

    Park Ridge, Illinois, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Jul 2005
Primary completion
1 Mar 2011
Completion
28 Nov 2011
Last update posted
4 Jun 2019
Registered enrollment
51
Registry id
NCT00234052

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.